We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
ClearPoint's (CLPT) Neuro Systems to Boost Neurosurgeries
Read MoreHide Full Article
ClearPoint Neuro, Inc. (CLPT - Free Report) recently announced the installation and completion of an initial procedure with both the ClearPoint Prism Neuro Laser Therapy System and the ClearPoint Neuro Navigation System at Kaleida Health in Buffalo, NY.
These technologies are expected to offer selected minimally invasive neurosurgical procedures to patients.
Price Performance
For the past six months, CLPT’s shares have gained 5.2% against the industry’s decline of 3.1%. The S&P 500 increased 6.8% in the same time frame.
Image Source: Zacks Investment Research
More on the News
The market's only non-cooled laser applicator is available with the ClearPoint Prism Neuro Laser Therapy System.
Next-generation laser applicator technology from ClearPoint reduces power and ablation time, lessens image artifact, and enables more efficient operations by doing away with the need for external cooling.
The Prism laser is presently available in limited supply at a few U.S. academic medical institutes.
Industry Prospects
Per a report by MarketsandMarkets, with a growth rate of 8.9%, the global laser technology market is expected to reach more than $25.6 billion by 2027.
The primary drivers of market expansion are the healthcare vertical's increasing demand and the growing output of nano and micro devices. Another important driver of the laser technology industry's expansion is the superior performance of laser-based techniques compared with conventional ways of material processing.
Notable Developments
The company recently announced its receipt of the FDA’s 510(k) clearance for its SmartFrame OR Stereotactic System.
The system is expected to offer flexible workflows to surgeons (including iCT forward projection), thereby enabling precise image-based corrections to achieve sub-millimetric accuracy.
Some better-ranked stocks to consider in the broader medical space are Universal Health Services (UHS - Free Report) , Integer Holdings Corporation (ITGR - Free Report) and Acadia Healthcare (ACHC - Free Report) .
Universal Health Services, carrying a Zacks Rank #2 (Buy) at present, has an estimated growth rate of 4.4% for 2024. UHS’s earnings surpassed estimates in all the trailing four quarters, delivering an average surprise of 5.47%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
UHS’s shares have gained 1.9% in the past six months against the industry’s 5% decline.
Integer Holdings, presently carrying a Zacks Rank of 2, has an estimated long-term growth rate of 15.8%. ITGR’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 11.9%.
Integer Holdings’ shares have rallied 43.5% in the past year against the industry’s 3.7% decline.
Acadia Healthcare, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 10.4%. ACHC’s long-term earnings are expected to grow at 11.2%.
Acadia’s shares have gained 11.7% in the past six months against the industry’s decline of 5%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
ClearPoint's (CLPT) Neuro Systems to Boost Neurosurgeries
ClearPoint Neuro, Inc. (CLPT - Free Report) recently announced the installation and completion of an initial procedure with both the ClearPoint Prism Neuro Laser Therapy System and the ClearPoint Neuro Navigation System at Kaleida Health in Buffalo, NY.
These technologies are expected to offer selected minimally invasive neurosurgical procedures to patients.
Price Performance
For the past six months, CLPT’s shares have gained 5.2% against the industry’s decline of 3.1%. The S&P 500 increased 6.8% in the same time frame.
Image Source: Zacks Investment Research
More on the News
The market's only non-cooled laser applicator is available with the ClearPoint Prism Neuro Laser Therapy System.
Next-generation laser applicator technology from ClearPoint reduces power and ablation time, lessens image artifact, and enables more efficient operations by doing away with the need for external cooling.
The Prism laser is presently available in limited supply at a few U.S. academic medical institutes.
Industry Prospects
Per a report by MarketsandMarkets, with a growth rate of 8.9%, the global laser technology market is expected to reach more than $25.6 billion by 2027.
The primary drivers of market expansion are the healthcare vertical's increasing demand and the growing output of nano and micro devices. Another important driver of the laser technology industry's expansion is the superior performance of laser-based techniques compared with conventional ways of material processing.
Notable Developments
The company recently announced its receipt of the FDA’s 510(k) clearance for its SmartFrame OR Stereotactic System.
The system is expected to offer flexible workflows to surgeons (including iCT forward projection), thereby enabling precise image-based corrections to achieve sub-millimetric accuracy.
ClearPoint Neuro, Inc. Price
ClearPoint Neuro, Inc. price | ClearPoint Neuro, Inc. Quote
Zacks Rank & Stocks to Consider
CLPT carries a Zacks Rank #3 (Hold) at present.
Some better-ranked stocks to consider in the broader medical space are Universal Health Services (UHS - Free Report) , Integer Holdings Corporation (ITGR - Free Report) and Acadia Healthcare (ACHC - Free Report) .
Universal Health Services, carrying a Zacks Rank #2 (Buy) at present, has an estimated growth rate of 4.4% for 2024. UHS’s earnings surpassed estimates in all the trailing four quarters, delivering an average surprise of 5.47%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
UHS’s shares have gained 1.9% in the past six months against the industry’s 5% decline.
Integer Holdings, presently carrying a Zacks Rank of 2, has an estimated long-term growth rate of 15.8%. ITGR’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 11.9%.
Integer Holdings’ shares have rallied 43.5% in the past year against the industry’s 3.7% decline.
Acadia Healthcare, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 10.4%. ACHC’s long-term earnings are expected to grow at 11.2%.
Acadia’s shares have gained 11.7% in the past six months against the industry’s decline of 5%.